ITAT directs AO to re-examine adjustments & deductions, incl. interest, TP, ESOP, depreciation.

The ITAT partly allowed the appeal, directing the AO to re-examine various adjustments and deductions. Specific directions were given on interest adjustments for short-term facilities and share application money, corporate guarantees, exclusion of specific incomes from operating profits, determination of Arm's Length Price, deduction of income corresponding to TP adjustments, disallowance under Section 10B, superannuation and gratuity contributions, ESOP expenses, apportionment of corporate overhead expenses, weighted deduction for clinical drug trials, disallowance under Section 14A, depreciation on non-compete fees, taxation of capital gains, and computation of book profits under Section 115JB.

---

---

Issues Involved:

1. Adjustment of interest on short-term facility extended to an Associated Enterprise (AE).
2. Adjustment of interest on share application money deposited with an AE.
3. Adjustment for corporate guarantees extended to AEs.
4. Exclusion of specific incomes from operating profits for Transfer Pricing (TP) adjustments.
5. Determination of Arm's Length Price (ALP) for sales to AEs.
6. Deduction of income corresponding to TP adjustment in another entity.
7. Deduction under Section 10B of the Income Tax Act.
8. Disallowance of superannuation and gratuity contributions.
9. Deduction of Employee Stock Option Scheme (ESOP) expenses.
10. Apportionment of common corporate overhead expenses.
11. Weighted deduction under Section 35(2AB) for clinical drug trials.
12. Disallowance under Section 14A for earning exempt dividend income.
13. Depreciation on non-compete fees.
14. Taxation of capital gains on property sale.
15. Computation of book profits under Section 115JB.

Detailed Analysis:

1. Adjustment of Interest on Short-Term Facility Extended to AE:
The Dispute Resolution Panel (DRP) confirmed the Transfer Pricing Officer's (TPO) adjustment of Rs. 6,57,51,298/- as interest on a short-term facility extended to Matrix Laboratories NV, Belgium, adopting a 14% interest rate. The assessee contended that the amounts advanced were for acquiring a controlling interest and should not attract interest. The ITAT directed the AO/TPO to adopt EURIBOR + 2% as the interest rate, considering previous ITAT orders and DRP's acceptance in earlier years.

2. Adjustment of Interest on Share Application Money Deposited with AE:
The DRP confirmed the TPO's adjustment of Rs. 8,04,750/- as interest on share application money deposited with Matrix Laboratories BV, Netherlands. The TPO treated this as a loan and applied a 14% interest rate. The ITAT, citing similar cases, held that the investment was in equity and not a loan, directing the deletion of the adjustment.

3. Adjustment for Corporate Guarantees Extended to AEs:
The DRP confirmed the TPO's adjustments of Rs. 19,11,68,600/- and Rs. 60,81,800/- for corporate guarantees extended to Matrix Laboratories NV, Belgium, and Mchem Pharma Group Ltd., China, respectively. The ITAT upheld the TP adjustments but reduced the guarantee commission rate from 2% to 0.53%, following precedents set by co-ordinate Bench decisions.

4. Exclusion of Specific Incomes from Operating Profits for TP Adjustments:
The DRP upheld the TPO's exclusion of Rs. 26,83,94,695/- from settlement of a patent infringement suit and Rs. 9,56,79,559/- from foreign exchange fluctuations from operating profits. The ITAT rejected the inclusion of the settlement income in operating profits but directed the inclusion of foreign exchange gains/losses as part of operating margins, aligning with precedents.

5. Determination of ALP for Sales to AEs:
The TPO rejected the assessee's comparables and selected new ones, leading to an adjustment of Rs. 16,50,00,000/-. The ITAT found the DRP had not adjudicated the objections and remanded the issue back to the TPO for re-examination of comparables with proper FAR analysis.

6. Deduction of Income Corresponding to TP Adjustment in Another Entity:
The DRP rejected the assessee's claim for deduction of Rs. 3,31,40,155/- related to TP adjustments in Astrix Laboratories Limited. The ITAT upheld this rejection, stating that taxability in one entity does not affect adjustments in another unless specified by law.

7. Deduction Under Section 10B of the Income Tax Act:
The DRP upheld the AO's disallowance of Rs. 80,31,79,402/- claimed under Section 10B for certain units, pending a High Court decision. The ITAT directed the AO to follow the High Court's decision once available.

8. Disallowance of Superannuation and Gratuity Contributions:
The DRP confirmed the AO's disallowance of Rs. 24,90,966/- for superannuation and Rs. 36,00,000/- for gratuity paid to directors. The ITAT allowed the deductions under Section 37, noting that the contributions were part of the directors' salaries and subjected to TDS.

9. Deduction of Employee Stock Option Scheme (ESOP) Expenses:
The DRP upheld the AO's disallowance of Rs. 5,46,85,050/- for ESOP expenses. The ITAT restored the issue to the AO for re-examination in light of the Special Bench decision in Biocon Limited, which allows ESOP expenses as deductible.

10. Apportionment of Common Corporate Overhead Expenses:
The DRP upheld the AO's higher allocation of corporate overheads, reducing the Section 10B benefit. The ITAT directed the AO to accept the assessee's rational allocation method based on cost accounting principles.

11. Weighted Deduction Under Section 35(2AB) for Clinical Drug Trials:
The DRP upheld the AO's disallowance of Rs. 2,26,00,589/- for clinical drug trials. The ITAT restored the issue to the AO for re-examination, directing consideration of the certification in Form 3CL.

12. Disallowance Under Section 14A for Earning Exempt Dividend Income:
The DRP upheld the AO's disallowance of Rs. 11,17,244/- under Section 14A. The ITAT reduced the disallowance to Rs. 1,00,000/-, considering it a reasonable expenditure for earning exempt income.

13. Depreciation on Non-Compete Fees:
The DRP upheld the AO's disallowance of depreciation on non-compete fees. The ITAT allowed depreciation on brought-forward WDV but rejected it for the current year's non-compete fees, following consistent ITAT views.

14. Taxation of Capital Gains on Property Sale:
The AO taxed the difference between the market value and sale consideration as short-term capital gain. The ITAT set aside the addition, noting that the capital gain was correctly offered in the earlier year, and the AO's action was not in accordance with the Act.

15. Computation of Book Profits Under Section 115JB:
The DRP upheld the AO's computation method. The ITAT directed the AO to compute book profits based on the decision in the assessee's own case, allowing the deduction of export profits from book profits without phasing out.

Conclusion:
The appeal was partly allowed for statistical purposes, with several issues remanded for re-examination by the AO, and specific directions given for others. The ITAT provided detailed guidance on the treatment of various adjustments and deductions, ensuring adherence to precedents and legal provisions.

---